Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-07-31
1992-04-28
Nucker, Christine
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530380, 530392, 530394, 530395, 530406, 530410, 530807, 530828, A61K 3704, C07K 1514, C07K 1700
Patent
active
051089874
ABSTRACT:
Conjugates of transferrin or ceruloplasmin with anti-tumour agents. Such conjugates are useful in the treatment of tumours. Suitable anti-tumour agents include adriamycin, daunomycin, methotrexate, vincristin, 6-mercaptopurine, cytosine arabinoside and cyclophosphamide. Transferrin or ceruloplasmin in preferably coupled to the anti-tumour agent by means of glutaraldehyde.
REFERENCES:
patent: 4046722 (1977-09-01), Rowland
patent: 4671958 (1987-06-01), Rodwell et al.
Faulk (1980) Lancet II (8191) 390-392.
Teale et al. (1977) Br. J. Clin. Pharmac. 4:169-172.
Wilchek (1979) Makromol. Chem. Suppl. 2 207-214.
Kim Kay K.
Nucker Christine
LandOfFree
Conjugates of proteins with anti-tumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugates of proteins with anti-tumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugates of proteins with anti-tumor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1249475